About Us

After obtaining a triple PhD (chemistry, physics, biology) in 2009, Pawel spent 7 years at Oxford University studying DNA technology at Departments of Physics, Biochemistry and Oncology. In 2017 he established DNA repair focused research group at Adam Mickiewicz University. 2018, the MNM Diagnostics was born as a need to bring genomics directly to patient's bed by merging genomics with AI technologies.

A graduate of Biotechnology at Adam Mickiewicz University in Poznań. A long-time employee of the DNA Sequencing Laboratory. She continued her scientific career at the University of Oxford, where she gained knowledge, experience and scientific independence.
After returning to Poland in 2017, together with a group of enthusiastic specialists/scientists, she founded the company MNM Diagnostics, where she conducts research and analyses on personalized diagnostics and the selection of anti-cancer targeted therapies.

Obtained his Ph.D. in 2014 at the University of Bergen, Norway. His thesis focused on sensitivity analysis of high-throughput bioinformatics workflows. During the PhD at the Computational Biology Unit, and afterwards as a postdoc fellow at the Center for Medical Genetics (MGM) at the Haukeland University Hospital in Bergen, Pawel gained broad experience in deep sequencing (NGS) data analysis, high performance and cloud computing, software engineering, and human genetics. He had an opportunity to play a pivotal role in establishing a clinical whole-exome sequencing facility at the hospital, and after returning to Poland, in building a microbial sequencing facility at the National Veterinary Research Institute in Puławy, Poland. After acquiring a prestigious MSCA funded fellowship, and successful completion of the project at the Medical University of Lodz, Pawel joined MNM to pursue the ambisius mission of introducing whole-genome sequencing into routine patient diagnostics. His current main role is leading a team of programmers, bioinformaticians, and data-scientists that work side by side with geneticists and clinical scientists to develop cutting edge diagnostic tools in cancer, and to enable whole genome sequencing at a population scale.

A graduate of Edinburgh Napier University. He initially gained experience in international institutions such as the JP Morgan investment bank, RBS and State Street Bank and Trust. After returning to Poland, he worked in the investment industry, both in asset management and an insurance company, where he was the head of the investment department. In addition, he also worked in the e-commerce industry, where he was responsible for all activities of the finance department. At MNM Bioscience, he is responsible for the company’s financial activities and supports the company in developing on a new market and co-creates a strategy for further development.